chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pins and Needles neuropathy, still hasn't gone away as of today at 6 ½ weeks.
Patient indicated feeling of nausea, arm became numb, head felt tight and a dull headache
don't feel like he was given the vaccine; This is a spontaneous report received from a contactable reporter(s) (Pharmacist), Program ID:.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "don't feel like he was given the vaccine".  Additional information: a patient who was administered with Covid-19 and don't feel like he was given the vaccine and pharmacist is asking if it's ok to administer again after 1 week.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
She was exhausted; Felt awful for a few days in a row; She threw up in the middle of the night; She got a killer headache; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient received bnt162b2 (BNT162B2), on 26Mar2021 as dose 2, single (Lot number: EP6955, Expiration Date: 30Jun2021) at the age of 60 years for COVID-19 immunisation. The patient's relevant medical history included: "GERD" (ongoing); "Had gall bladder removed" (unspecified if ongoing). Concomitant medications included: ESOMEPRAZOLE taken for gastrooesophageal reflux disease (ongoing). Vaccination history included: bnt162b2 (dose 1, single; lot number: EN6202; expiration date: 30Jun2021), administration date: 05Mar2021, when the patient was 60-year-old, for COVID-19 immunisation, reactions: "Felt awful for a few days in a row", "She was exhausted", "She threw up in the middle of the night", "She got a killer headache". The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "She was exhausted"; MALAISE (non-serious), outcome "unknown", described as "Felt awful for a few days in a row"; VOMITING (non-serious), outcome "unknown", described as "She threw up in the middle of the night"; HEADACHE (non-serious), outcome "recovered", described as "She got a killer headache". Therapeutic measures were taken as a result of headache. Additional information: The patient reported that for her reactions with her prior COVID shots, states one time she threw up in the middle of the night and the first two laid her low like she was exhausted and felt awful for a few days in a row and another one she got a killer headache with that Tylenol could not get rid of and had that a day or two and then after the immunization, she would feel better the next day after 2-3 days of misery, she would wake up feeling perfectly normal the next day. She and her friends would say that the previous symptoms they all had for throwing up and feeling and bad headaches and all that was just due to the immunization as was widely reported with a lot of people. She states she does not know which dose of her COVID vaccines the headache and throwing up were associated with. For the other patients or friends she spoke with that had symptoms after having the COVID vaccinations, she has no patient specific information to provide, no names or manufacturers of their vaccines, no lots.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300311369 same patient, vaccine, and event; different dose;US-PFIZER INC-202300311395 same patient and vaccine; different dose and event;
7 pm aching legs 12:30 am fever 102 12:30 twitching, teeth chattering, seizure like movements, 2:00am headache
OBSTRUCTIVE SLEEP APNEA ACUTE NON ST ELEVATION MI MYOCARDITIS
Immediately following the vaccine administration on 8/7/17 pt developed pain in R deltoid (site of the MENACTRA). Pain gradually worsened. Today pain is severe in the arm. Mother reports onset today of the following: sore throat, fatigue, lightheadedness, nausea with vomiting (one episode at 11AM today), and chills. Temp of 100. R deltoid is mildly swollen but no redness.
HE WAS FEELING THE SYMPTOMS THAT PEOPLE WAS FEELING BEFORE THE SHOTS; HE WAS FEELING SICK; HOT FLASHES; This spontaneous report received from a parent via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient already had medical issues in the past but was fine before the shots. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 28-JAN-2022, the patient experienced hot flashes. On an unspecified date, the patient experienced he was feeling the symptoms that people was feeling before the shots, and he was feeling sick. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the hot flashes, he was feeling the symptoms that people was feeling before the shots and he was feeling sick was not reported. This report was non-serious.
Clicking of the shoulder joint, severe pain in shoulder, reduced range of motion, weakness, Bursitis and Tendinosis of rotator cuff muscles.
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unknown age and gender. On an unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 lot # L014458 with expiration date: 11-FEB-2017 and lot # L034335 with expiration date: 18-MAY-2017 (dose and route of administration were not reported). Administered doses of vaccines experienced the temperature excursion of 35.6 degrees Fahrenheit for 10 minutes and 36.6 degrees Fahrenheit for 10 minutes. Data logger was involved. There were no previous excursions. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I have been really brain fogged; weird like feeling in her legs and it hardly lasted for five minutes but it came with weakness/ same sensation in my arms, in arm that I got shot in and it came with hand weakness; I had a weird like feeling in my legs and it hardly lasted for five minutes but it came with weakness and it felt like a short of energy or anxiety; I had a weird like feeling in my legs and it hardly lasted for five minutes but it came with weakness and it felt like a short of energy or anxiety; Lethargy; Very tired; My heart kind of feel like it is pounding out from the chest like off and on throughout the day; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, on 17Jan2021 as a single dose, for COVID-19 immunization, lot number: unknown. Medical history and concomitant medications were not provided. Patient got the vaccine on 17Jan2021 and she had been really brain fogged and on Tuesday and Wednesday she had a weird like feeling in her legs and it hardly lasted for five minutes but it came with weakness and it felt like a short of energy or anxiety and then Friday evening, patient had the same sensation in her arms, in arm that she got shot in and it lasted for about ten minutes and it came with hand weakness and then she had no muscle pain necessarily but lethargy, very tired and her heart kind of feel like it was pounding out from the chest like off and on throughout the day, events occurred on unknown date in Jan2021. Patient called the doctor and he said to wait but it is kind of there now, so she had an appointment on Wednesday. Outcome of the events was unknown. Information on the lot/batch number has been requested.
Pt went home fr clinic; Awoke fr nap w/very high pitched cry which was unconsolable-called MD wished child to have ped DT;
A 50 year old female with a medical history of epilepsy since age 13 and brain surgery in Feb 1999 received a .25ml injection of Influenza vaccine, lot number unk, on 19Oct05 at 1:30PM. The route and site of administration and number of previous doses were also unk. Ten hrs later at 11:15PM, the pt experienced a staring seizure (not grand mal) and could not walk. The duration of the seizure was 30 minutes. Illness at the time of vaccination and other medications were unk. The last documented seizures were 23Aug05, 03Aug05 and 23Mar05. The pt's next neurology visit is scheduled for 11Nov05. At the time of this report, the pt had recovered.
I experienced an immediate metallic taste in my mouth. My pulse shot up to the 120s-130s and stayed elevated for about 12-24 hours. My body felt like it was in fight or flight for about 6-7 days. I had foul smelling diarrhea, weakness, fatigue and fevers. I have been experiencing random blood pressure spikes since being vaccinated and also cardiac issues. I saw two different allergists to get opinions on whether or not I should receive my 2nd dose. I also saw a cardiologist and had an echocardiogram done. My echo showed mild pulmonary hypertension which I have never had before.
Vesicular rash; This case was reported by a nurse via call center representative and described the occurrence of vesicular rash in a 87-year-old female patient who received Herpes zoster (Shingrix) (batch number 353S5, expiry date 31st May 2021) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on 1st April 2019).   On 24th July 2019, the patient received the 2nd dose of Shingrix (intramuscular). In July 2019, 1 day after receiving Shingrix, the patient experienced vesicular rash. The patient was treated with antivirals nos, antivirals nos, antivirals nos, antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the vesicular rash was recovering/resolving.   It was unknown if the reporter considered the vesicular rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left deltoid. The patient had a generalized vesicular rash that started 24 to 48 hours after the Shingrix vaccination.  The patient was improving and was being treated with antiviral medications. The reporter consented to follow up and provided contact details.
p/vax pt rash raised ``like mosquito bites'' stated rash spread to ``all over''; no other symptoms x/itching; counselled to take pt to MD; phone disconnected before sent
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 25-FEB-2016, the patient was vaccinated with the first dose of M-M-R II (dose, route of administration, lot# and expiration date were not reported). There were no symptoms reported. Additional information has been requested.
Started having excess weight gain, heart palpitations, ?asthma? symptoms 2017, extreme weight loss, debilitating panic attacks, overheating, and digestive issues 2018, 2019+: extreme weight gain, sleep disturbances, food intolerances such as gluten, dairy, nightshades, grains, skin rough patches on arms, extreme plaque buildup on scalp, anxiety, horrible joint pain and ultimately the diagnoses of an autoimmune disorder (Hashimoto?s thyroiditis).
"had covid shot, then developed aching in his L side of face and aching in his L ear. This started 4d ago. no fever. He is using otc drops. not helping."
I started to get an Arrhythmia; Palpitation; I am dizzier; this is aggravating of my pre-existing conditions/my acid reflux is no longer base line; This spontaneous case was reported by a patient and describes the occurrence of ARRHYTHMIA (I started to get an Arrhythmia) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dizziness since 1992, Malabsorption, Anaemia since 1992, LBBB since 26-Feb-2021 and GERD since 2000. Concomitant products included ALUMINIUM HYDROXIDE, MAGNESIUM TRISILICATE, SODIUM ALGINATE (PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]) for Acid reflux (oesophageal), ALPRAZOLAM for Imbalance hormonal.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARRHYTHMIA (I started to get an Arrhythmia) (seriousness criterion medically significant), PALPITATIONS (Palpitation), DIZZINESS (I am dizzier) and CONDITION AGGRAVATED (this is aggravating of my pre-existing conditions/my acid reflux is no longer base line). At the time of the report, ARRHYTHMIA (I started to get an Arrhythmia), PALPITATIONS (Palpitation), DIZZINESS (I am dizzier) and CONDITION AGGRAVATED (this is aggravating of my pre-existing conditions/my acid reflux is no longer base line) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood pressure measurement (120-80): 184/110 (High) high and high (High) 140-150/80-90. In 2021, Heart rate: high (High) Rise in pulse rate.         Patient have numerous allergies which are not reported. Treatment information provided included 1mg of unknown medication. Action taken with mRNA-1273 in response to the events was not applicable.  Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-080355 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Client stated that she felt her throat swelling  and she was not feeling well. She was given Benadryl, EMS was called and when they arrived they evaluated the patient. Her husband brought her to the emergency room.
Redness, swelling, and itching at site of injection starting 5 days after injection and ending 6 days after injection.
Localized reaction around vaccine site. Swelling, redness, itch. Lasted 3 days.
Patient c/o "shoulder" pain x 1 month after HPV vaccine. X-ray shoulder - neg. MD examined - deltoid area discomfort - mild, no limited ROM.
Fever to max of 104 by oral thermometer. Extremely tender left arm and injection site with redness locally, mild induration, and no fluctuance. Given Augmentin orally/antipyretics.
A non-serious report of vaccination error has been received from a physician concerning a three year-old female. This case is submitted in accordance with post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FLUMIST. The child has a history of allergy to eggs, no drug history information has been reported for this child. The patient received FLUMIST intranasally. On 29-Oct-2007 the reporter indicated a child with a history of allergy to eggs was inadvertently administered FLUMIST. No adverse events were observed. Outcome: the child had no ill effects verified on 04-Feb-2008. Further dosing with FLUMIST is not indicated. The reporter did not provide a causality assessment for this vaccination error. The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable. Follow up information was received 4-15-08. Adverse event onset date, states no adverse event reported and lot for vaccine is 500490P, 2/11/08. Follow up obtained on 06-Feb-2008 verified no adverse event was experienced and the physician approved dosing this child with FLUMIST.
After the second vaccination my general discomfort increased tiredness fatigue headache my legs hurt my hips wanting to vomit weakness.
After I got the first dose, I experienced fever, headaches, sore arm; After I got the first dose, I experienced fever, headaches, sore arm; After I got the first dose, I experienced fever, headaches, sore arm; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9264), via an unspecified route of administration, administered in left arm on 06Feb2021 at 16:30 (at age of 57 years old, no pregnant at vaccination) at a single dose, for COVID-19 immunization. Medical history included Known allergies: food reactions to shrimps, crabs, lobsters- and occasionally to pineapples, avocado and eggs; also had reactions to penicillin, sulfa- type medications. Other medical history: none. There were no concomitant medications. No other vaccine in four weeks and no other medications in two weeks. After the patient got the first dose, she experienced fever, headaches, sore arm-however they went away in a couple of days. The outcome of the events was recovered.
After receiving vaccine, pt experienced nausea, vomiting, chills and has a 7 cm diameter inflamed area at injection site.
Sharp pains in feet (neuropathy); Bad diarrhea; Felt yucky and not feeling good at all; Arm swollen on the same side of injection; A spontaneous report was received from a consumer who was also a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced sharp pains in feet (neuropathy)/ neuropathy peripheral, arm swollen on same side of injection/ injection site swelling, bad diarrhea/ diarrhea, and feeling yucky and not good at all/ malaise.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 03 Feb 2021, approximately at 12:00 pm, the patient received their first of two planned doses of mRNA-1273 (Lot number: 010M20A) intramuscularly for prophylaxis of COVID-19 infection.   On 04 Feb 2021, the patient started experiencing symptoms of sharp pains in his feet (neuropathy), bad diarrhea, felt yucky and not feeling good at all.   On 05 Feb 2021, the patient reported that the symptoms did not abate, however they were improving.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome for the events, sharp pains in feet (neuropathy), arm swollen on same side of injection, bad diarrhea and felt yucky and not good at all, was resolving.; Reporter's Comments: Based on the current available information and a  temporal association between the use of the product and the onset of the reported events a causal relationship cannot be excluded.  Injection site swelling is consistent with the known safety profile of the vaccine.
I am post menopausal, I am bleeding and have period like symptoms; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), at 52 years old via an unspecified route of administration, administered in Arm Left on 28Apr2021 10:30 as 2nd dose, single for COVID-19 immunization in a public health department. Medical history included diagnosed with COVID-19 and post menopausal both from an unknown date. Concomitant medications include an unspecified medication taken within two weeks of vaccination. The patient received the first dose of bnt162b2 on 07Apr2021 11:00 AM for COVID-19 immunization. On 04May2021 08:30, the patient reported that she is post menopausal, was bleeding and have period like symptoms. The reporter considered the event as non-serious. No treatment was given. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
arm w/much discomfort shoulder to elbow-very painful on movement started following day p/vax;vax given 22OCT97 feeling better by 24OCT through 30OCT when pain started again;
vaccine was accidentally given one day after its expiration date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine was accidentally given one day after its expiration date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine was accidentally given one day after its expiration date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine was accidentally given one day after its expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine was accidentally given one day after its expiration date).    Concomitant medication was not reported. Treatment drug was not reported.
Clots in left arm after taking 2 shots; Swollen arm after 2 vaccine shots; pain in left arm; 50 days gap between 2 vaccine doses; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROMBOSIS (Clots in left arm after taking 2 shots) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Idiopathic thrombocytopenic purpura, Spina bifida and Psoriasis.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Clots in left arm after taking 2 shots) (seriousness criterion medically significant), PERIPHERAL SWELLING (Swollen arm after 2 vaccine shots), VACCINATION SITE PAIN (pain in left arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50 days gap between 2 vaccine doses). The patient was treated with APIXABAN (ELIQUIS) at a dose of 25 mg twice a day and APIXABAN (ELIQUIS) at a dose of 5 mg twice a day. At the time of the report, THROMBOSIS (Clots in left arm after taking 2 shots), PERIPHERAL SWELLING (Swollen arm after 2 vaccine shots) and VACCINATION SITE PAIN (pain in left arm) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50 days gap between 2 vaccine doses) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: abnormal (abnormal) clot in the left arm.         Patient went to emergency after 3 weeks of taking Moderna COVID-19 second Vaccine.  No relevant concomitant medications were reported Reportedly, the treatment with Apixaban (Eliquis) needed to continue for 6 months.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.